The article you requested is
Dr Portella and Colleagues Reply
J Clin Psychiatry 2011;72(11):1558 [letter]
Copyright 2011 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $40
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP print + online for $166 individual.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
To the Editor: In his letter to the editor, Prof Terao doubts whether pindolol can enhance, apart from accelerate, the antidepressant effect of selective serotonin reuptake inhibitors (SSRIs).
As correctly stated by Prof Terao, a number needed to treat (NNT) higher than 10 is not clinically meaningful, and therefore an NNT of 13 regarding late clinical response is not relevant. The results of our meta-analysis show that pindolol accelerates antidepressant effects within the first 4 weeks, but not for any longer, as previously reported by Ballesteros and Callado1 and Whale et al.